Final ID: Mo1150
Manalo Kathryn, Tieliwaerdi Xiarepati, Jackson Megan, Arrigo Alexis, Mascara Mariah, Maharjan Srijana, Gadani Mrudula
Bleeding with the FXI Inhibitor Abelacimab compared with Rivaroxaban in Patients on Antiplatelet therapy: A Prespecified Analysis of the AZALEA-TIMI 71 TrialAl Said Samer, Goodman Shaun, Joung Boyoung, Kiss Robert, Spinar Jindrich, Wojakowski Wojciech, Weitz Jeffrey, Bloomfield Dan, Sabatine Marc, Ruff Christian, Patel Siddharth, Giugliano Robert, Morrow David, Goodrich Erica, Murphy Sabina, Hug Bruce, Parker Sanobar, Chen Shih-ann